USPTO 2015–2025 USPTO PatentsView US Corporation

Biomet Biologics, LLC

USPTO PatentsView assignee record - 65 granted patents across 27 technology areas, recorded in grant years 2015–2021. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).

RSS updates for this company

The verdict

According to USPTO PatentsView, Biomet ranks #5,263 of 49,997 tracked US assignees by granted-patent volume, with 65 patents across 27 technology areas.

#5,263
of 49,997 US assignees by volume
Top 26%
by Innovation Score (44.2/100)
19.0
avg claims per patent
-93%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R5263 · US Corporation #5,263 · 65 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

  • GRANTS-SMALL 65 grants
  • UPPER-Q #5,263/49,997
  • PHOTO-FINISH Anthony
  • CPC-FOCUS A61M · 27 areas
  • INNOV-PAR 44.2/100
  • CLAIMS-RICH 19.0 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-DROP -93% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Anthony, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Biomet

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Biomet's Innovation Score is 44.2/100 (top 26% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Where Biomet's grants concentrate

Biomet Biologics, LLC is a focused PatentsView assignee: 27 CPC subclasses with 56.9% of grants classified under A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor). Peak complete grant year is 2017 (19 grants) versus a trough of 2 in 2020. By volume, Biomet sits between AZ Electronic Materials (Luxembourg) S.A.R.L. and Croda International PLC.

Who files at Biomet's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Biomet holds 65 patents at rank #5,265, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Biomet

By rank, the assignees closest to #5,265 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media Into)

Other assignees with the most granted patents in Biomet's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Biomet, neither rank-band nor same-CPC leaders (those blocks stay above). In A61M (Devices FOR Introducing Media Into), Biomet ranks #198 of 3,490 assignees by patent count in that subclass.

Biomet's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

44 Top 26% higher than 74% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

05101520 2015201620172018201920202021 2
USPTO utility patent grants by year · 2015–2021

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Biomet Biologics, LLC patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 18 27.7%
2016 7 10.8%
2017 19 29.2%
2018 13 20.0%
2019 4 6.2%
2020 2 3.1%
2021 2 3.1%

Which technologies does Biomet Biologics, LLC patent most?

Top 15 of 27 technology areas

Where it ranks

Overall rank by patents

#5,263

of 49,997 tracked assignees

Innovation Score

44.2 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Biomet Biologics, LLC's patent record in context - here's where to go next.

  • Biomet Biologics, LLC's lead technology class is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor), 56.9% of its portfolio - see every assignee active in that class. Explore A61M
  • Ranked #5,263 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Biomet Biologics, LLC against AZ Electronic Materials (Luxembourg) S.A.R.L., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 44.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.